Blockade of Endocannabinoid Hydrolytic Enzymes Attenuates Precipitated Opioid Withdrawal Symptoms in Mice

Δ(9)-Tetrahydrocannbinol (THC), the primary active constituent of Cannabis sativa, has long been known to reduce opioid withdrawal symptoms. Although THC produces most of its pharmacological actions through the activation of CB(1) and CB(2) cannabinoid receptors, the role these receptors play in red...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ramesh, Divya, Ross, Gracious R., Schlosburg, Joel E., Owens, Robert A., Abdullah, Rehab A., Kinsey, Steven G., Long, Jonathan Z., Nomura, Daniel K., Sim-Selley, Laura J., Cravatt, Benjamin F., Akbarali, Hamid I., Lichtman, Aron H.
Formato: Artigo
Idioma:Inglês
Publicado em: The American Society for Pharmacology and Experimental Therapeutics 2011
Assuntos:
Behavioral Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3186294/
https://ncbi.nlm.nih.gov/pubmed/21719468
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/jpet.111.181370
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados